Today: 21 May 2026
IREN stock rises again as Bernstein’s “top AI pick” call meets a bitcoin rebound
13 January 2026
1 min read

IREN stock rises again as Bernstein’s “top AI pick” call meets a bitcoin rebound

New York, Jan 13, 2026, 09:55 (ET) — Regular session

  • IREN Limited stock was up about 2% in early trade, extending a sharp gain from Monday.
  • A Bernstein note calling IREN a “top AI pick” has kept focus on the Microsoft AI cloud contract and funding needs.
  • Traders are watching crypto prices and the next earnings update for progress on the build-out.

IREN Limited (IREN) shares rose about 1.9% to $51.28 in early Nasdaq trade on Tuesday, extending a rally that gathered pace at the start of the week.

The move matters now because IREN sits at the crossroads of two crowded trades — crypto-linked cash flows and the rush to add AI computing capacity — and both are prone to sudden reversals.

After Monday’s surge, investors are pressing the company’s story harder: can it line up funding, build capacity on time and keep the Microsoft contract on track without leaning too heavily on the equity market?

Bitcoin climbed about 1.9% to $92,477, helping lift shares of crypto miners including Marathon Digital, Riot Platforms and CleanSpark in early trading.

IREN ended Monday up 9.34% at $50.33, with trading volume near 52 million shares as the stock caught a fresh bid across retail and momentum screens.

Bernstein analyst Gautam Chhugani called IREN “our top AI pick” for 2026 and urged investors to “start 2026 by buying stocks on the dip,” TipRanks reported, adding that he lifted his IREN price target to $75. The same item said J.P. Morgan analyst Reginald Smith reaffirmed a Sell rating this week. TipRanks

IREN has been in the spotlight since Microsoft signed a $9.7 billion, five-year contract with the company that includes access to Nvidia’s advanced chips, Reuters reported in November. The deal includes a 20% prepayment, and it can be terminated if IREN fails to meet delivery schedules.

But the trade still cuts both ways. Building AI data centers is expensive and slow, and any hint of delays, tighter financing conditions or fresh dilution could hit the stock quickly — especially if bitcoin turns lower and drags the sector with it.

Next up, investors will look for IREN’s next quarterly results, which Nasdaq’s earnings page estimates around Feb. 11, for a clearer read on spending, timing and how much new capital the company may need.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk
Previous Story

Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk

AMD stock jumps on KeyBanc upgrade as analyst flags tight 2026 server CPU supply
Next Story

AMD stock jumps on KeyBanc upgrade as analyst flags tight 2026 server CPU supply

Go toTop